• Users Online: 643
  • Print this page
  • Email this page
Year : 2022  |  Volume : 14  |  Issue : 2  |  Page : 84-88

Post-COVID-19 infection: Mucormycosis – A tertiary care hospital experience

Department of Pathology, Government Medical College, Patiala, Punjab, India

Correspondence Address:
Kanwardeep Kaur
Department of Pathology, GMC, Patiala, Punjab
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ajprhc.ajprhc_23_22

Rights and Permissions

Background: Mucormycosis is an opportunistic infection which has increased in the recent times of upsurge of cases of covid 19. Secondary infection by mucormycosis is noticed in individuals with low immune status, patients on steroid and oxygen therapy. Aims and Objectives:The aim was to analyse mucormycosis cases post covid19 as per age, gender, site of involvement, hospitalization status, site involvement and treatment outcome of patients. Materials and Methods: A retrospective study was conducted on specimens received in the Department of Pathology, over a period of 1 year in which 29 cases of mucormycosis were included. Specimens received in the laboratory were fixed in 10% formalin and submitted to detailed gross examination. Proper orientation in eye exenteration specimens and meticulous examination of the debridement specimens was done along with submission of representative sections in all the cases. Sections were then stained with H and E stain and special stain i.e., PAS and examined microscopically. Results: In this study, 29 patients over a period of 1 year are presented from a tertiary care center out of which 19 are males and 10 females, 82.75% patients with mucormycosis are covid 19 positive. Nasal cavity and maxillary sinus are most common sites involved. Survival rate in these patients is high due to early diagnosis and treatment. Conclusion: Hence, the present study emphasizes on the high incidence of mucormycosis in Covid 19 patients with predisposing factors mainly immunocompromised status, hospitalized patients. To prevent the occurrence of mucormycosis, early identification and further investigation of this fungus will significantly reduce the severity of the disease and mortality rate in Covid 19 affected patients.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded54    
    Comments [Add]    

Recommend this journal